Anne Katrine Bergland
Stilling
Førsteamanuensis
Tilhørighet
Publikasjoner
Vitenskapelig artikkel
- Siri Lerstøl Olsen; Marte Johanne Tangeraas Hansen; Elin Bø Lunde et al. (2026). Delirium in older adults in the emergency department: a scoping review of current research and identified knowledge gaps. (ekstern lenke)
- Yong Li; Melanie Le Sayec; Yifan Xu et al. (2026). (Poly)phenol and methylxanthine metabolites and their association with cognitive and cardiometabolic health in older people. (ekstern lenke)
- Chiara De Lucia; Diego Alejandro Tovar-Rios; Khadija Khalifa et al. (2025). Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID). (ekstern lenke)
- Yohannes Seyoum Demissie; Chiara De Lucia; Khadija Khalifa et al. (2025). Gut enterotype- and body mass index (BMI)-dependent effects of anthocyanin supplementation on gut microbiota composition in individuals at risk for cognitive decline: a randomized placebo-controlled trial. (ekstern lenke)
- Mathias Nikolai Petersen Hella; Hogne Sønnesyn; Hanne Brit Hetland et al. (2025). Delirium prevalence and incidence in acutely admitted older patients: an observational cohort study. (ekstern lenke)
- Mathias Nikolai Petersen Hella; Nathalie Bodd Halaas; Hogne Sønnesyn et al. (2025). Neurogranin in cerebrospinal fluid as a marker of synaptic dysfunction in hip fracture patients with delirium: a multicentre cross-sectional study. (ekstern lenke)
- Dag Aarsland; Khadija Khalifa; Anne Katrine Bergland et al. (2022). A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia. (ekstern lenke)
- Miguel Germán Borda; George E. Barreto; Jonathan Patricio Baldera et al. (2024). A randomized, placebo-controlled trial of purified anthocyanins on cognitive function in individuals at elevated risk for dementia: Analysis of inflammatory biomarkers toward personalized interventions. (ekstern lenke)
- Anne Katrine Bergland; Ingvild Dalen; Alf Inge Larsen et al. (2016). Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia. (ekstern lenke)
- Ragnhild Oesterhus; Ingvild Dalen; Anne Katrine Bergland et al. (2020). Risk of Hospitalization in Patients with Alzheimer’s Disease and Lewy Body Dementia: Time to and Length of Stay. (ekstern lenke)
- Miguel Germán Borda; Robinson Ramírez-Vélez; Felipe Botero rodriguez et al. (2025). Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects. (ekstern lenke)
- Anne Katrine Bergland; Petroula Proitsi; Bjørn-Eivind Kirsebom et al. (2020). Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease. (ekstern lenke)
- Anne Katrine Bergland; Hogne Sønnesyn; Ingvild Dalen et al. (2019). Effects of anthocyanin supplementation on serum lipids, glucose, markers of inflammation and cognition in adults with increased risk of dementia - A pilot study. (ekstern lenke)
- Khadija Khalifa; Anne Katrine Bergland; Hogne Sønnesyn et al. (2020). Effects of purified anthocyanins in people at risk for dementia: Study protocol for a phase II randomized controlled trial. (ekstern lenke)